GLL398
Product Specifications
UNSPSC Description
GLL398 is a potent, orally bioavailable selective estrogen receptor degrader (SERD) with an IC50 value of 1.14 nM. GLL398 shows a strong dose-dependent binding to ER with a mutation at Y537S (IC50=29.5 nM). GLL398 blocks tumor growth in xenograft models of breast cancer.
Target Antigen
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gll398.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
OC(/C=C/C(C=C1)=CC=C1/C(C2=CC=C(B(O)O)C=C2)=C(C3=CC=CC=C3)/CC)=O
Molecular Weight
398.26
References & Citations
[1]Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180(2):359-368.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101119/GLL398-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101119/
Clinical Information
No Development Reported
CAS Number
2077980-80-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1484263 Inquire
Recombinant Coccidioides immitis Elongation factor G, mitochondrial (MEF1), partial
Ask
View Details 
